DCM
EPIX

DAFNA Capital Management’s ESSA Pharma EPIX Stock Holding History

DAFNA Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,902
Closed -$289K – 75
2016
Q4 		$289K Sell
4,902
-4,873
-50% -$212K 0.25% 58
2016
Q3 		$733K Sell
9,775
-350
-3% -$18.7K 0.51% 48
2016
Q2 		$810K Hold
10,125
– – 0.64% 47
2016
Q1 		$662K Sell
10,125
-1,300
-11% -$84.8K 0.57% 50
2015
Q4 		$1.04M Hold
11,425
– – 0.93% 30
2015
Q3 		$1.42M Buy
+11,425
New +$1.59M 1.41% 20

Other funds holding EPIX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

DAFNA Capital Management's EPIX Position: Q1 2017 in Review

DAFNA Capital Management sold out of ESSA Pharma (EPIX) in Q1 2017, closing a stake of 4,902 shares — an estimated $289K sold.

DAFNA Capital Management first reported a position in EPIX in Q3 2015 and held it in 6 quarters. The position peaked at $1.42M in Q3 2015. 10 funds tracked by Wall St. Rank hold EPIX as of Q1 2017.

  • DAFNA Capital Management reported no remaining ESSA Pharma position as of Q1 2017 after selling out during the quarter.
  • DAFNA Capital Management sold 4,902 ESSA Pharma shares in Q1 2017, an estimated $289K.
  • DAFNA Capital Management first reported a position in ESSA Pharma in Q3 2015 and held it in 6 quarters.
  • DAFNA Capital Management's ESSA Pharma position peaked at $1.42M in Q3 2015.
  • 10 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2017.

Based on DAFNA Capital Management's 13F filing for Q1 2017, filed 15 May 2017.